Researchers sought to determine whether patients who are functional high-risk had a worse prognosis even without having traditional high-risk features.
The 5-year recurrence-free survival rate was 75% in the younger age group and 73% in the older age group. Age may not be a prognostic factor for patients with cervical cancer, according to ...
Researchers conducted a randomized controlled trial to assess the need for postoperative radioiodine therapy among patients with low-risk thyroid cancer.
The results of this first phase 2 study of belzutifan combined with cabozantinib suggest that dual targeting of HIF-2α and VEGF pathways might be an effective first-line treatment strategy in advanced ...
Researchers developed an assay kit for TAT, then conducted a retrospective analysis to determine its ability to predict VTE in patients with cervical cancer.